2019
DOI: 10.1523/jneurosci.0674-19.2019
|View full text |Cite
|
Sign up to set email alerts
|

p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model

Abstract: Alzheimer's disease (AD) is associated with the cleavage of the amyloid precursor protein (APP) to produce the toxic amyloid-␤ (A␤) peptide. Accumulation of A␤, together with the concomitant inflammatory response, ultimately leads to neuronal death and cognitive decline. Despite AD progression being underpinned by both neuronal and immunological components, therapeutic strategies based on dual targeting of these systems remains unexplored. Here, we report that inactivation of the p110␦ isoform of phosphoinosit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 60 publications
3
11
0
Order By: Relevance
“…WT = wild type C57BL/6 cognitive decline [26]. Furthermore, elevated systemic TNF-α produces acute cognitive dysfunction and inhibition TNF-α trafficking prevents cognitive decline in an Alzheimer's disease mouse model [27]. Our previous study also demonstrated that MV-induced neuroinflammation affected postoperative memory dysfunction and TLR4 knockout ameliorates neuroinflammation.…”
Section: Discussionmentioning
confidence: 94%
“…WT = wild type C57BL/6 cognitive decline [26]. Furthermore, elevated systemic TNF-α produces acute cognitive dysfunction and inhibition TNF-α trafficking prevents cognitive decline in an Alzheimer's disease mouse model [27]. Our previous study also demonstrated that MV-induced neuroinflammation affected postoperative memory dysfunction and TLR4 knockout ameliorates neuroinflammation.…”
Section: Discussionmentioning
confidence: 94%
“…Although essentially unable to cross the blood-brain barrier [ 36 ], this inhibitor nevertheless exhibited in vitro outcomes consistent with the ability, should it be administered perispinally to ensure it reaches the brain [ 3 ] in order to reduce TNF and thus neuroinflammation in a mouse model of AD. As might be expected, genetically inactivating this kinase produced the same TNF and neuroinflammation outcomes in vivo as the inhibitor did in vitro , as well as reducing cognitive decline [ 37 ]. Notably, a range of other anti- or proinflammatory cytokines were unaffected.…”
Section: The Key Relevance Of Tnf In All These Conditionsmentioning
confidence: 88%
“…Studies on the roles of the delta family of phosphoinosositide 3-kinases (PI3Ks) of cytokine signaling pathways independently demonstrate the centrality of TNF in models of stroke [ 36 ] and AD [ 37 ], the most common members of the rapid and slow onset groups respectively. This has been achieved in a stroke model by inhibiting one of this family of kinases, which reduced TNF trafficking and secretion of lipopolysaccharide-induced TNF in macrophages [ 38 ].…”
Section: The Key Relevance Of Tnf In All These Conditionsmentioning
confidence: 99%
“…Similar to observations in gliomas, dysregulation of PAM-dependent mechanisms is observed in age-related neurodegenerative conditions, suggesting their contributions to CNS disease progression in aging. Indeed, PAM induction of aberrant cell cycle progression, impaired autophagy and neuroinflammation is implicated in AD pathogenesis [ 136 138 ]. Additionally, data suggest that patients displaying AD symptomology maintain poorer cancer-related outcomes, including diagnosis with more advanced stages of cancer, decreased life expectancies and increased mortality rates [ 139 143 ].…”
Section: Potentiation Of Glial Pam In Aging: Potential Mechanisms Inmentioning
confidence: 99%